The healthcare industry continues to be a hotbed of innovation, with activity driven by telemedicine, real-time diagnostics, smart hospitals and access to digital therapies, and the growing importance of technologies such as artificial intelligence (AI), the internet of things (IoT), augmented reality (AR), robotics and data management practices. In the last three years alone, there have been over 106,000 patents filed and granted in the healthcare industry, according to GlobalData’s report on Artificial Intelligence in Healthcare: Automated genetic screening.

However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilising and reaching maturity.

Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.

200+ innovations will shape the healthcare industry

According to GlobalData’s Technology Foresights, which plots the S-curve for the healthcare industry using innovation intensity models built on over 443,000 patents, there are 200+ innovation areas that will shape the future of the industry.

Within the emerging innovation stage, drug delivery device security, microscopic image analysis models, and cellular imaging techniques are disruptive technologies that are in the early stages of application and should be tracked closely. Smart balloon catheters, automated immunoassay analysers, and AI-assisted magnetic resonance imaging (MRI) are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas are smart fitness training system and non-invasive physiological monitoring, which are now well established in the industry. 

Innovation S-curve for artificial intelligence in the healthcare industry

Automated genetic screening is a key innovation area in artificial intelligence

Genetic screening is the process of evaluating members of a community to determine who is more likely to have or acquire a certain genetic condition or to possess a genetic variation for that disorder. Businesses are adopting artificial intelligence-backed automation to speed up the workflow for genetic screening in such an attempt to expand the number of illnesses that can be tested for and the volume of samples that can be examined.

GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 90+ companies, spanning technology vendors, established healthcare companies, and up-and-coming start-ups engaged in the development and application of automated genetic screening.

Key players in automated genetic screening – a disruptive innovation in the healthcare industry  

‘Application diversity’ measures the number of different applications identified for each relevant patent and broadly splits companies into either ‘niche’ or ‘diversified’ innovators.

‘Geographic reach’ refers to the number of different countries each relevant patent is registered in and reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.

Patent volumes related to automated genetic screening

Company Total patents (2010 - 2021) Premium intelligence on the world's largest companies
Illumina 294 Unlock company profile
Waters 158 Unlock company profile
NantWorks 103 Unlock company profile
BostonGene 89 Unlock company profile
Caris MPI 87 Unlock company profile
Laboratory Corp of America Holdings 76 Unlock company profile
Natera 71 Unlock company profile
Koninklijke Philips 57 Unlock company profile
Psomagen 56 Unlock company profile
F. Hoffmann-La Roche 48 Unlock company profile
Myriad Genetics 45 Unlock company profile
Guardant Health 43 Unlock company profile
Mayo Clinic 43 Unlock company profile
OPKO Health 40 Unlock company profile
Exact Sciences 37 Unlock company profile
Orig3N 33 Unlock company profile
Regeneron Pharmaceuticals 26 Unlock company profile
Veracyte 26 Unlock company profile
Arctic Partners 25 Unlock company profile
SureGene 25 Unlock company profile
Nestle 24 Unlock company profile
BioNTech 23 Unlock company profile
Genetic Technologies 23 Unlock company profile
Sysmex 20 Unlock company profile
Worldwide Innovative Networking in personalized cancer medicine consortium 20 Unlock company profile
Five3 Genomics 20 Unlock company profile
Merck & Co 20 Unlock company profile
Access Business Group International 20 Unlock company profile
Adaptive Biotechnologies 19 Unlock company profile
Abbott Laboratories 18 Unlock company profile
Agilent Technologies 17 Unlock company profile
AbbVie 15 Unlock company profile
Chang Gung Memorial Foundation 14 Unlock company profile
SomaLogic 14 Unlock company profile
Asia Genomics 13 Unlock company profile
Nant Holdings Ip 13 Unlock company profile
Arctic Partners 13 Unlock company profile
BillionToOne 12 Unlock company profile
iRepertoire 12 Unlock company profile
Celmatix 12 Unlock company profile
InVitae 12 Unlock company profile
Health Research 11 Unlock company profile
Amgen 11 Unlock company profile
Genedata 11 Unlock company profile
Synaptamine 10 Unlock company profile
Cold Spring Harbor Laboratory 10 Unlock company profile
Johnson & Johnson 10 Unlock company profile
Eurofins Scientific 10 Unlock company profile
Population Bio 10 Unlock company profile
Scipher Medicine 9 Unlock company profile

Source: GlobalData Patent Analytics

Illumina is one of the leading patent filers in the field of automated genetic screening. Some other key patent filers in the field include Waters and NantWorks. In terms of application diversity, Waters leads the pack, followed by Johnson & Johnson and Arctic Partners, respectively. By means of geographic reach, OPKO Health held the top position, followed by Arctic Partners and Genedata in second and third spots, respectively.

Automated Genetic screening is expected to expand in the future as individuals’ vulnerability to illness will frequently be predicted by genetic screening. Results from tests can reduce ambiguities and assist people in making confident decisions about how to manage their healthcare.

To further understand how artificial intelligence is disrupting the healthcare industry, access GlobalData’s latest thematic research report on Artificial Intelligence (AI) in Healthcare.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Patent Analytics tracks patent filings and grants from official offices around the world. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.